HFA Premium Access

Effects of pre-existing heart failure with preserved ejection fraction (HFpEF) on the outcomes of patients with COVID-19: a systematic review

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Jieling Chen

AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)
1 presentation
0 follower

4 more presentations in this session

Therapeutic effects of urocortin-2 in Heart Failure with preserved Ejection Fraction

Speaker: Miss I. Vasconcelos (Porto, PT)

Thumbnail

Clinical and prognostic relevance of cardiac wasting in patients with advanced cancer

Speaker: Doctor A. Lena (Berlin, DE)

Thumbnail

The role of miR-146a in the pathophysiology of pulmonary arterial hypertension - therapeutic implications

Speaker: Miss J. Santos Peixoto Gomes (Porto, PT)

Thumbnail

Inward Displacement: a novel method for regional left ventricular functional assessment in HFrEF

Speaker: Associate Professor R. Puri (Cleveland, US)

Thumbnail

Access the full session

Basic & Translational Late-Breaking Science

Speakers: Doctor J. Chen, Miss I. Vasconcelos, Doctor A. Lena, Miss J. Santos Peixoto Gomes, Associate Professor R. Puri
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by